AtheroGenics Shares Fall on Study Concerns
CHICAGO, March 9 (Reuters) - AtheroGenics Inc. (AGIX.O: Quote, Profile , Research) shares fell as much as 31 percent before recovering somewhat on Friday as investors bet results from a make-or-break study would show the drugmaker's experimental heart medicine failed to meet its goal.